CEVIMELINE HCL 30 MG CAPSULE

cevimeline hydrochloride
$0.7172per EA
High Outlier

Strength

30 mg/1

NDC

00713093701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

CEVIMELINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA020989

On Market Since

1/3/2023

Pharmacological Classes

Cholinergic Muscarinic Agonists
Cholinergic Receptor Agonist

Price History

1W

0.0%

1M

+2.8%

3M

+9.1%

6M

+1.6%

1Y

+1.9%

3Y

N/A

5Y

N/A

All

-42.0%